This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Company Filing History:
1 out of 834,350 Years Active: 2001
Title: Jacqueline Arp: Innovator in Viral Protein Research
Introduction
Jacqueline Arp is a notable inventor based in London, Canada. She has made significant contributions to the field of virology, particularly in the study of human T-cell lymphotropic virus type II (HTLV-II). Her work focuses on the isolation and purification of envelope proteins, which are crucial for understanding viral infections.
Latest Patents
Jacqueline Arp holds a patent for the "Human T-cell lymphotropic virus type II envelope protein and human monoclonal antibodies specific therefor." This patent describes the isolated and purified envelope protein of HTLV-I, which is devoid of non-envelope proteins and maintains a conformation similar to that of the native HTLV-I envelope protein. The protein is produced recombinantly using a dual vaccinia/T7 polymerase system. Both non-glycosylated and glycosylated forms of the protein are produced, with glycosylated forms being recognized by antibodies specific to the HTLV-I envelope protein. Additionally, monoclonal antibodies specific for the HTLV-I envelope protein are provided, which do not bind to the denatured form of the protein. The HTLV-I envelope protein is cross-reactive with antibodies of HTLV-II and STLV, making it useful for diagnosing infections caused by HTLV-I and HTLV-II.
Career Highlights
Throughout her career, Jacqueline has demonstrated a commitment to advancing the understanding of viral proteins and their implications in human health. Her innovative research has positioned her as a key figure in the field of virology.
Collaborations
Jacqueline has collaborated with esteemed colleagues such as Gregory A Dekaban and Steven Kok Hing Foung. These partnerships have further enriched her research and contributed to the advancement of knowledge in viral studies.
Conclusion
Jacqueline Arp's contributions to the field of virology, particularly through her patent on HTLV-I envelope proteins, highlight her role as an innovator in medical research. Her work not only enhances our understanding of viral infections but also aids in the development of diagnostic tools.